BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2472826)

  • 21. Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.
    Pelley RJ; Bukowski RM
    Curr Opin Oncol; 1997 Jan; 9(1):68-74. PubMed ID: 9090496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of interferons in the management of carcinoid tumours.
    Oberg K; Eriksson B
    Br J Haematol; 1991 Oct; 79 Suppl 1():74-7. PubMed ID: 1834159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carcinoid tumors].
    Tóth M; Prónai L; Németh AM; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in chemotherapy and biotherapy of endocrine tumors.
    Oberg K
    Curr Opin Oncol; 1998 Jan; 10(1):58-65. PubMed ID: 9466486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
    Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
    Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
    Kaltsas GA; Mukherjee JJ; Isidori A; Kola B; Plowman PN; Monson JP; Grossman AB; Besser GM
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):169-83. PubMed ID: 12153595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.
    Oberg K; Norheim I; Lind E; Alm G; Lundqvist G; Wide L; Jonsdottir B; Magnusson A; Wilander E
    Cancer Treat Rep; 1986 Nov; 70(11):1297-304. PubMed ID: 2429764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
    Juby LD; Burke DA; Axon AT
    Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
    Ben Yosef R; Glaser B; Catane R
    Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.
    Raderer M; Kurtaran A; Scheithauer W; Fiebiger W; Weinlaender G; Oberhuber G
    Oncology; 2001; 60(2):141-5. PubMed ID: 11244329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients.
    Eriksson B; Oberg K; Skogseid B
    Acta Oncol; 1989; 28(3):373-7. PubMed ID: 2472825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of interferons in the management of carcinoid tumors.
    Oberg K; Eriksson B
    Acta Oncol; 1991; 30(4):519-22. PubMed ID: 1854509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors.
    Arnold R; Neuhaus C; Benning R; Schwerk WB; Trautmann ME; Joseph K; Bruns C
    World J Surg; 1993; 17(4):511-9. PubMed ID: 8395752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of carcinoid tumors of the digestive tract].
    Votte A; Cattan D; Dupas JL
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1031-42. PubMed ID: 8729416
    [No Abstract]   [Full Text] [Related]  

  • 36. Somatostatin-receptor imaging in the localization of endocrine tumors.
    Lamberts SW; Bakker WH; Reubi JC; Krenning EP
    N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of unresectable malignant endocrine tumors of the pancreas.
    Modlin IM; Lewis JJ; Ahlman H; Bilchik AJ; Kumar RR
    Surg Gynecol Obstet; 1993 May; 176(5):507-18. PubMed ID: 8386860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.
    Kim YH; Ajani JA; Carrasco CH; Dumas P; Richli W; Lawrence D; Chuang V; Wallace S
    Cancer Invest; 1999; 17(7):474-8. PubMed ID: 10518191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes.
    Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K
    Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.